Summary of Workshop on Psychosocial Factors in Coronary Heart Disease: Measurement, Evaluation, and Intervention by DEMIROVIĆ, J. & EPSTEIN, F. H.
European Heart Journal (1988) 9, 687-689
Summary of Workshop on Psychosocial Factors in
Coronary Heart Disease: Measurement, Evaluation,
and Intervention
J. DEMIROVIC* AND F. H. EPSTEIN!
*Department of Scientific Research and Development, University Clinical Centre, Pasterova 2,11000
Belgrade, Yugoslavia, and ^ Institute of Social and Preventive Medicine, University of Zurich, Switzerland
4.
The European Society of Cardiology Working
Group on Epidemiology and Prevention and the
Yugoslav Society of Cardiology jointly sponsored
this workshop which was held in Dubrovnik,
Yugoslavia, on 23-25 April 1987.
A group of 23 experts (see Appendix) from various
disciplines (epidemiologists, clinicians, psycholo-
gists, neuropsychiatrists, sociologists), together
with a similar number of invited observers, met to
assess the state of the art in the field of psychosocial
factors and their role in coronary heart disease
(CHD), to discuss conceptual and methodological
problems in assessing these factors, to explore the
prospects of using present results in the prevention
of CHD, and to develop suggestions for future
research.
Four main issues were addressed in the frame-
work of panel discussions:
(1) Epidemiological and Clinical Approaches:
Study Designs;
(2) Use of Questionnaires, Interviews, and
Psychological Tests;
(3) 'Efferent Pathways': Biochemical and
Physiological Measurements; and
(4) Intervention Studies.
A mini-session on 'Health Behaviour and Health
Education' took place on the end of the workshop.
A selection of working papers prepared for the
workshop are published in this issue of the European
Heart Journal. The following is a short summary of
the discussions and recommendations made, with
suggestions for new research needs.
Epidemiology of health behaviour
Studies of the epidemiology of health behaviour
in different population groups have been identified
Paper presented al the ESC Workshop on Psychosocial Factors in
Coronary Heart Disease, Dubrovnik, Yugoslavia, 23-25 April 1987.
as an area of high priority for future research, with
the aims:
(1) to understand causes of risk behaviour,
especially social causes;
(2) to identify high-risk groups;
(3) to explore potential links between social/
cultural factors and cardiovascular disease;
(4) to provide guidance for promoting changes
in risk behaviour by means of'conventional'
health education or by other social/economic/
political approaches to change; and
(5) to examine the links between knowledge, atti-
tudes, and behaviour as well as the reasons
for non-compliance with health education,
and with other kinds of intervention.
As most of the past and present epidemiological
studies of psychosocial variables in CHD are con-
cerned with middle-aged western European and
American men, there is an ultimate need to assess
these variables in different ethnic groups among
both women and men and including younger age
groups.
Design of studies linking psychosocial factors to
disease risk
Cross-sectional epidemiological studies have
limitations and are generally used to search for, but
not to test, hypotheses. However, their broader use
in the field of psychosocial factors should be kept in
mind. Such studies may provide valuable data on
the epidemiology of psychosocial factors in a wide
sense, indicating which people behave in a healthy
or unhealthy way, what are the group and indi-
vidual differences, and how psychosocial factors
vary with social structure, cultural patterns, level of
economic development, and other influences.
In assessing the aetiological role of psychosocial
factors in CHD, prospective study design is the
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design of choice, and these factors should be in-
cluded in the baseline measurements of all new
major prospective studies. CHD clinical end-points
(angina, fatal and non-fatal myocardial infarction,
sudden and non-sudden CHD death) need to be
considered separately rather than as a group.
It is important to identify path models before
using multivariate statistical methods to adjust for
other known CHD risk factors: if a covariable is an
intermediate step in a causal chain between the psy-
chosocial factor of interest and the dependent vari-
able, controlling for such a factor may diminish or
eliminate the relationship between the psychosocial
factor and CHD.
Repeated measurements of psychosocial vari-
ables over time would help to provide more accur-
ate estimates of their impact on CHD morbidity
and mortality, i.e. longitudinal effect of exposure.
The recent development of statistical methods,
which allows for multiple regression analysis using
covariables that change over time, seems to hold
much promise in analyzing longitudinal data.
Historical prospective study design may also be
useful in assessing the relationship between the
psychosocial factors and CHD, because a huge
amount of data has already been collected.
In spite of a number of disadvantages, retrospec-
tive or case-control studies in assessing the relation-
ship between the psychosocial factors and CHD
(systematic and selection biases, effects attributable
to the disease itself, recall bias, etc.) should not be
neglected, particularly in evaluating secondary pre-
vention measures related to psychosocial factors
(such as counselling or drug therapy verified by
medical records).
Measurement
A great deal of earlier research work on the
relationship of psychosocial factors and CHD was
concerned with the measurement of personality
characteristics and type of behaviour. However,
accumulating evidence indicates that both the indi-
vidual and the social environment must be taken
into consideration.
Much criticism has been addressed to the Type-A
behaviour measures which are presently used in
epidemiological studies. The general opinion was
that different components of the Type-A behaviour
construct should be considered separately in assess-
ing their role in CHD. Potential for hostility and an
inability or unwillingeness to express anger ('anger-
in') have been found as the 'toxic' components of
the Type-A behaviour construct. As self-report
measures do not accurately measure anger and
potential for hostility, multi-method assessment
of an individual Type-A behaviour has been
recommended. It has been underlined that better
standardization of Type-A behaviour pattern
assessment is essential for future research work in
this field.
Personality characteristics should be assessed in
a dynamic model (coping style), especially in
threatening/demanding situations rather then in the
static models mostly used in the past.
Acute physiological reactivity to behavioural
stimuli is an important variable to be measured as
part of epidemiological studies. A standard defi-
nition of reactivity and instrumentation to measure
reactivity are needed, as well as easily administered
reactivity-eliciting procedures for use in such
studies.
It has been well established that neuroendocrine
reactions to behavioural stimuli involve cate-
cholamines, corticosteroids, sex hormones, insulin,
growth hormone, as well as a number of effects on
carbohydrate, lipid and electrolyte metabolism.
From the point of view of the feasibility of including
these markers in the baseline measurements of the
epidemiological studies, 24-h urine and plasma
catecholamines and cortisol levels, lipid metab-
olism indicators, such as LDL and HDL, and co-
agulation indicators, such as fibrinogen, have been
recommended, together with physiological
measurements, such as 24-h blood pressure and
ECG monitoring.
From the wide range of psychosocial variables
relevant to CHD, job characteristics and social
support seem to be of prime importance, because
they are affected by individual characteristics and
are also closely bound with the social environment.
In measuring and assessing job characteristics, it is
necessary that modifications of the Karasek model
are applied to non-industrial populations. The
effects of work and family strain on women's car-
diovascular health has been identified as an area of
high priority for future research.
Social networks (i.e. the structure and quantity of
social ties) and social support, which represents
their function and quality, need to be measured in a
more standardized manner. Future studies should
aim to make a distinction between the main effect of
social support (lack of which may be a stressor/?er
se) and the buffer effect (lack of social support may
only be harmful in the presence of a significant life
stressor).
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Research is also needed in relating biochemical
and physiological variables to the personality
characteristics and coping style, to job character-
istics (particularly to demand/decision latitude
ratio), and to social support.
It has been underlined that, regardless of the con-
tent of the psychosocial variables assessed, stan-
dard tests and scales should be used which have
documented inter- and intra-individual reliability
and documented validation statistics.
Intervention
There is reasonably good evidence that psycho-
social intervention can alter both classic and
behavioural risk factors, and all new studies on
multi-factorial risk intervention should include
psychosocial-factor modification. Work on treat-
ing hypertension by stress management added to the
belief that non-pharmacological intervention is
possible. The examples taken from the experience
gathered by the studies in which therapeutic modifi-
cation of Type-A behaviour pattern was under-
taken (including stress management, cognitive
therapy, cognitive-behavioural therapy, and beta
blockers) suggested that the recurrence of coronary
events can be reduced.
Taking into account both the individual and
social nature of cognition and emotions, the most
promising approach for the future modification of
health behaviour and prevention of CHD seems to
be the utilization of the social support concept.
Various techniques might be applied, such as family
education, health education in patient groups
which also provide stress management and social
support, peer support and peer interaction, medical
self-help groups, and others. There is some evidence
that women are more likely then men to attend
meetings which utilize social support techniques
and that low-income groups have the highest drop-
out rate. Additional evidence from field trails are
needed to justify extending the implementation of
this concept to CH D prevention programmes at the
population level.
Stress management at the working place has been
identified as an area of great importance, and more
practical and less costly methods to be applied in
such settings are highly recommended.
Since health education plays an extremely
important role in changing behaviour for health,
success in stress management depends a great deal
on understanding different models of health
behaviour. It is crucial that educational principles
are developed through the use of these models.
In conclusion, this workshop has emphasized
again that a close collaboration between scientists
from varied disciplines is essential to make progress
in the very complex field of psychosocial factors and
their effects on human health. General concern
about the need for improved mutual communi-
cation and information led to the proposal for
establishing a Working Party or Committee on
Psychosocial Factors in collaboration with the
European Society of Cardiology and the World
Health Organization. One of the immediate tasks of
such a Working Party would be to bring together
researchers who already have data on psychosocial
factors in order to try and bring their results under
some common denominator.
It is hoped that these proposals will be put into
action in the near future, so that psychosocial fac-
tors will cease to be 'second class' risk factors.
This workshop was also supported by the Council of
Communities for Science of the SFR Yugoslavia, Adminis-
tration for International Scientific, Educational, Cultural,
and Technical Cooperation of SFR Yugoslavia, and The
British Council.
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